You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis

Fig. 3

Longitudinal analysis of IP-10 levels in patients with active TB stratified by risk of relapse. Longitudinal (a) serum, (b) urine IP-10, and (c) urine IP-10/creatinine ratio obtained throughout treatment (T0, T2, and T6) were analysed in risk subgroups (low-risk and moderate/ high-risk groups) using locally weighted scatterplot smoothing (LOESS) and confidence intervals of the mean (CLM)

Back to article page